Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 219 institutions that hold shares in the stock, with a total of 70.1 Million shares, which have been reported (via 13F filing form) to have a value of $2.07 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
5,741,666
shares
|
$170 Million
3.12% of portfolio
|
Q1 2025
Added 1.32%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
4,584,859
shares
|
$136 Million
1.68% of portfolio
|
Q1 2025
Added 1.42%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
3,789,197
shares
|
$112 Million
0.03% of portfolio
|
Q1 2025
New holding
|
|
|
Janus Henderson Group PLC
London, X0 |
May 15, 2025 Q1 2025 |
3,325,093
shares
|
$98.3 Million
0.06% of portfolio
|
Q1 2025
Added 15.99%
|
|
|
Capital International Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
3,088,730
shares
|
$91.3 Million
0.02% of portfolio
|
Q1 2025
Added 21.26%
|
|
|
Braidwell LP
Stamford, CT |
May 15, 2025 Q1 2025 |
2,709,875
shares
|
$80.1 Million
5.58% of portfolio
|
Q1 2025
Reduced 7.0%
|
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2025 Q1 2025 |
2,623,039
shares
|
$77.6 Million
0.59% of portfolio
|
Q1 2025
Reduced 2.77%
|
|
|
Commodore Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
2,325,000
shares
|
$68.8 Million
7.64% of portfolio
|
Q1 2025
Reduced 15.15%
|
|
|
Capital World Investors
Los Angeles, CA |
May 12, 2025 Q1 2025 |
2,224,715
shares
|
$65.8 Million
0.01% of portfolio
|
Q1 2025
Reduced 3.04%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,095,894
shares
|
$62 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.23%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
2,032,730
shares
|
$60.1 Million
0.09% of portfolio
|
Q2 2023
Added 1.42%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
1,914,749
shares
|
$56.6 Million
0.12% of portfolio
|
Q1 2025
Added 2.75%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
1,477,617
shares
|
$43.7 Million
0.06% of portfolio
|
Q1 2025
Reduced 1.26%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
May 09, 2025 Q1 2025 |
1,391,370
shares
|
$41.1 Million
0.24% of portfolio
|
Q1 2025
Added 20.24%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
1,357,602
shares
|
$40.1 Million
0.0% of portfolio
|
Q1 2025
Added 0.05%
|
|
|
Alliancebernstein L.P.
New York, NY |
May 15, 2025 Q1 2025 |
1,329,386
shares
|
$39.3 Million
0.02% of portfolio
|
Q1 2025
Reduced 7.88%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
1,328,175
shares
|
$39.3 Million
4.97% of portfolio
|
Q1 2025
Added 14.38%
|
|
|
Vestal Point Capital, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,300,000
shares
|
$38.4 Million
3.11% of portfolio
|
Q1 2025
Added 60.49%
|
|
|
Samlyn Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
1,016,381
shares
|
$30.1 Million
0.56% of portfolio
|
Q1 2025
Reduced 0.14%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
1,000,000
shares
|
$29.6 Million
1.17% of portfolio
|
Q1 2025
Added 491.25%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
947,877
shares
|
$28 Million
0.99% of portfolio
|
Q4 2024
Added 4.0%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
931,681
shares
|
$27.5 Million
1.87% of portfolio
|
Q1 2025
Reduced 25.58%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 14, 2025 Q1 2025 |
796,986
shares
|
$23.6 Million
0.02% of portfolio
|
Q1 2025
Reduced 44.57%
|
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
776,693
shares
|
$23 Million
0.02% of portfolio
|
Q1 2025
Reduced 3.1%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2025 Q1 2025 |
758,145
shares
|
$22.4 Million
0.03% of portfolio
|
Q1 2025
Reduced 15.74%
|